Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma (1998)
- Authors:
- USP affiliated authors: FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM ; BRENTANI, MARIA MITZI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM
- Unidade: FM
- Assunto: MEDICINA INTERNA
- Language: Inglês
- Imprenta:
- Publisher: Monduzzi Editore
- Publisher place: Rio de Janeiro
- Date published: 1998
- Conference titles: International Cancer Congress
-
ABNT
DIZ, M. D. P. E et al. Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma. 1998, Anais.. Rio de Janeiro: Monduzzi Editore, 1998. . Acesso em: 14 fev. 2026. -
APA
Diz, M. D. P. E., Castro Junior, G., Snitcovsky, I., Folgueira, M. A. A. K., Leite, L. A. S., Vernieri, J. P. C., et al. (1998). Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma. In . Rio de Janeiro: Monduzzi Editore. -
NLM
Diz MDPE, Castro Junior G, Snitcovsky I, Folgueira MAAK, Leite LAS, Vernieri JPC, Brentani MM, Federico MHH. Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma. 1998 ;[citado 2026 fev. 14 ] -
Vancouver
Diz MDPE, Castro Junior G, Snitcovsky I, Folgueira MAAK, Leite LAS, Vernieri JPC, Brentani MM, Federico MHH. Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma. 1998 ;[citado 2026 fev. 14 ] - Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer
- Estudo da ploidia e indice proliferativo (fase s) por citometria de fluxo em carcinomas invasivos do colo uterino
- Transforming growth factor expression in head and neck cancer
- C-ERBB-2 negativo após quimioterapia neoadjuvante (QN) prediz sobrevida livre de doença (SLD) mais longa em pacientes com câncer de mama
- Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer
- Disease free survical in breast cancer with high flowcytometric S phase fraction in Brazilian patients
- Tumor infiltrating lymphocytes express cd 1 b and beta4 integrin chain
- Thymocyte subpopulations and clonality in myasthenia gravis
- Flow-cytometric dna analysis and hormonal receptor status in brazilian breast cancer patients
- Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
